D - Description
|
Quality
Management |
Training and
Education |
Public
Involvement |
| Description | |
|---|---|
Name |
ITCC - Innovative Therapies for Children and Adolescents with Cancer |
| Year of foundation | 2003 |
| Preterm and/or term newborn | No |
| Infants from 1 month to less than 24 months of age | Yes |
| Children from 2 years to less than 12 years of age | Yes |
| Adolescents from 12 years to less than 18 years | Yes |
| Paediatric age ranges of study participants covered by the network | 0-18 |
| Multispeciality? Specify | Paediatric malignancies, haematological malignancies and malignant solid tumours |
| Speciality/disease specific? Specify | From biology research, pharmacology and preclinical evalutation to phase I and II clinical trials in all paediatric and adolescent cancers |
| Conditions covered? Specify | All paediatric and adolescent cancers |
| Procedure/Intervention specific? Specify | Anti-tumour therapeutics |
| Number of collaborating countries | 17 |
| List of collaborating countries | AUSTRIA, BELGIUM, CZECH REPUBLIC, DENMARK, FINLAND, FRANCE, GERMANY, IRELAND, ISRAEL, ITALY, THE NETHERLANDS, NORWAY, POLAND, SPAIN, SWEDEN, SWITZERLAND, THE UK |
| Number of collaborating centres | 62 |
| List of collaborating centres | St. Anna Children's Hospital Medical University of Vienna Ghent University University Hospital Motol Prague Rigshospitalet Copenhagen Tampere University Hospital Helsinki University Hospital La Timone, Marseille CHRU Nancy CHU Nantes Institut Curie Centre Leon Berard Lyon Gustave Roussy Trousseau Paris Centre Oscar Lambret Lille CHU Bordeaux CHU Toulouse Robert Debré Paris Olgahospital Stuttgart UniversitaetsKlinikum Münster UniversitaetsKlinikum Frankfurt University of Freiburg University Medical Center Schleswig-Holstein, Kiel charite Universitatsmedizin, Berlin KiTZ Heidelberg University Children's Hospital Essen University Hospital of Cologne University Medical Center Augsburg University Medical Center Hamburg Eppendorf Children's Health Ireland Schneider Children's Medical Center of Israel Rambam Medical Center Haifa University of Padova Fondazione IRCCS Istituto Nazionale Tumori,Milan Gaslini Institute Genova Universita La Cattolica (A. Gemelli) Rome Ospedale San Gerardo Monza Ospedale Infantile Regina Margherita Torino Ospedale Bambino Gesu Rome Prinses Maxima Centrum Utrecht Oslo University Hospital Klinika Onkologii i Hematologii Dziecięcej, Krakow Hospital Universitario La FE Valencia Hospital Universitari Vall d'Hebron Barcelona Hospital Sant Joan de Deu Barcelona Hospital del Nino Jesus Madrid La Paz University Hospital - IdiPAZ Madrid Astrid Lindgren Children's Hospital, Karolinska,Stockholm Queen Silvia Children's and Adolescents' Hospital, Gothenburg University Children's Hospital Zuerich CHUV Lausanne Great Ormond Street GOSH London UCLH NHS TRUST London Leeds Teaching Hospitals NHS Trust Bristol Royal Hospital for Children Birmingham Children's Hospital Royal Marsden NHS Foundation Trust Sutton Royal Hospital for Sick Children, Yorkhill, Glasgow Addenbrookes Hospital Cambridge Royal Manchester Children's Hospital Newcastle University Alder Hey Children’s NHS Foundation Trust, Liverpool |
| Type of activity/studies | |
| Clinical Studies | Yes |
| Experimental research | Yes |
| Other activity | - Training and Education in the field of development of new anticancer drugs in children and adolescents - Advice on Anticancer Drug development in pediatric and adolescents oncology for Industry and regulatory authorities - Research in Methodology and Statistics - Development of guidelines and research on ethics, in collaboration with parents |